Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
THC · against 104 other Healthcare companies of similar size
Ranked #102 of 105 · scores higher than 3% of peers · safety percentile 3
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)10 peers with a safety percentile of 0–9, including THC · Click a bar to see the companies
Mainly because of its debt / equity, beta and current ratio, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | THC | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 102 reported | 1.52× | 0.45× | 10% | 33% | |
| BetaLower is better · 104 reported | 1.23 | 0.69 | 13% | 33% | |
| Current ratioHigher is better · 100 reported | 1.41× | 1.91× | 29% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 10.1B EUR (≈$11.1B) | 99 | ||
| 2 | 26.0B USD | 93 | 28 | |
| 3 | 12.6B USD | 89 | ||
| 4 | 20.0B AUD (≈$13.2B) | 84 | 77 | |
| 5 | 25.8B USD | 83 | 75 | |
| 98 | 14.6B USD | 8 | 59 | |
| 99 | 11.6B USD | 6 | 57 | |
| 100 | 23.5B USD | 5 | 27 | |
| 101 | 14.5B USD | 5 | 30 | |
| 102 | 21.5B USD | 3 | 60 | |
| 103 | 34.0B USD | 3 | 49 | |
| 104 | 14.0B USD | 2 | 31 | |
| 105 | 16.5B USD | 0 | 37 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score